R&D Tax Credit for Healthcare Companies: Complete 2026 Guide
R&D Tax Credit for Healthcare Companies: Complete 2026 Guide
Why R&D Tax Credits Matter for Healthcare Companies
The healthcare industry is one of the most research-intensive sectors in the U.S. economy. From developing new medical devices to conducting clinical trials and building innovative digital health platforms, healthcare companies invest billions annually in research and development activities.
Yet many healthcare organizations leave significant tax savings on the table by failing to claim R&D tax credits they’re entitled to. According to IRS data, healthcare companies claim only a fraction of available credits compared to other high-R&D industries like software and manufacturing.
The opportunity is substantial:
- Medical device companies average 8-12% of revenue in R&D spending
- Digital health startups invest heavily in platform development
- Hospital systems develop proprietary protocols and systems
- Clinical research organizations conduct extensive trials
This guide will help healthcare companies of all sizes identify qualifying activities, calculate potential credits, and navigate the documentation requirements for successful R&D tax credit claims.
Key Takeaways
- Healthcare R&D activities qualify: Medical device development, clinical trials, digital health platforms, EHR customization, and telemedicine systems all potentially qualify for R&D credits
- Credit value ranges from 6-10% of QREs: Using the Alternative Simplified Credit (ASC) method, expect approximately 6-10% of qualifying research expenses as a credit
- Documentation is critical: Maintain contemporaneous records showing how activities meet the four-part test (permitted purpose, technological uncertainty, process of experimentation, qualified nature)
- Don’t overlook clinical trials: Phase I-III clinical trials often contain qualifying components, especially in early phases with higher uncertainty
- Software development counts: Digital health platforms, mobile health apps, EHR integrations, and AI diagnostic tools are qualifying software development activities
- Common mistakes to avoid: Insufficient documentation, failing to allocate wages properly, and excluding contractor expenses
What Healthcare Activities Qualify for R&D Credit
Healthcare companies engage in numerous activities that can qualify for R&D tax credits under IRC Section 41. The key is understanding which activities meet the four-part test requirements.
The Four-Part Test for Healthcare R&D
To qualify, activities must meet all four criteria:
- Permitted Purpose: Developing a new or improved business component (product, process, software, formula, or technique)
- Technological Uncertainty: Uncertainty about capability, method, or design that can only be resolved through experimentation
- Process of Experimentation: Systematic evaluation of alternatives through modeling, simulation, or testing
- Technological in Nature: Relies on principles of physical or biological science, engineering, or computer science
Qualifying Healthcare Activities
Medical Device Development
- Design and prototyping of new devices
- Testing for FDA approval
- Iterative design improvements
- Biocompatibility testing
Clinical Research and Trials
- Phase I-III clinical trials (especially Phase I and II with higher uncertainty)
- Development of new treatment protocols
- Clinical data analysis systems
- Patient recruitment algorithms
Digital Health and Health IT
- Telemedicine platform development
- Mobile health applications
- AI diagnostic tools
- Patient engagement platforms
Electronic Health Records (EHR)
- Custom EHR module development
- Integration with third-party systems
- Data analytics dashboards
- Interoperability solutions
Biotechnology and Pharmaceuticals
- Drug discovery research
- Formulation development
- Manufacturing process optimization
- Quality control testing methods
Medical Device Development
Medical device companies represent some of the strongest candidates for R&D tax credits due to the inherently experimental nature of device development.
Qualifying Medical Device Activities
| Activity | Typical Qualification Level |
|---|---|
| Conceptual design and prototyping | High - Clear experimentation and uncertainty |
| FDA pre-market approval testing | High - Systematic evaluation of safety/efficacy |
| Biocompatibility studies | High - Biological uncertainty resolution |
| Design iteration based on testing | High - Process of experimentation evident |
| Manufacturing process development | Medium-High - Depends on novelty |
| Routine quality control | Low - Usually not qualifying (production activity) |
Case Study: Medical Device R&D Credit
Company: Mid-sized orthopedic device manufacturer Annual Revenue: $50M R&D Activities:
- Development of new spinal implant system
- 3D printing process optimization
- Material testing for durability
- FDA 510(k) submission preparation
Qualifying QREs:
- Engineer wages: $1,200,000
- Supplies and materials: $180,000
- Contract testing services: $220,000
- Total QREs: $1,600,000
Credit Calculation (ASC Method):
- Prior 3-year average QREs: $1,400,000
- 50% of excess QREs: ($1,600,000 - $1,400,000) × 50% = $100,000
- Credit: $100,000 × 20% = $20,000
Alternative (Regular Method):
- 20% of QREs above base amount
- Credit: Approximately $150,000
The difference illustrates why many medical device companies benefit from calculating both methods and choosing the higher credit.
Clinical Trials and Research
Clinical trials present unique opportunities and challenges for R&D tax credit claims. Not all clinical trial activities qualify, but many do—particularly in early phases.
Which Clinical Trial Phases Qualify?
Phase I Trials:
- Qualification Level: High
- Why: Highest degree of uncertainty about safety, dosing, and human response
- Qualifying Activities: Protocol development, patient monitoring, data analysis, safety evaluations
Phase II Trials:
- Qualification Level: Medium-High
- Why: Efficacy uncertainty still present, dose optimization continues
- Qualifying Activities: Efficacy testing, statistical analysis, protocol refinement
Phase III Trials:
- Qualification Level: Lower (but still possible)
- Why: Primary focus shifts to confirmation and regulatory approval
- Qualifying Activities: May qualify if significant uncertainty remains about efficacy or optimal protocols
Qualifying Clinical Trial Expenses
Directly Qualifying:
- Principal investigator time on protocol development
- Research coordinator activities for experimental procedures
- Data management for experimental endpoints
- Statistical analysis for hypothesis testing
Potentially Qualifying:
- Patient recruitment if novel methods used
- Monitoring activities for safety signals
- Laboratory tests for experimental biomarkers
Generally Not Qualifying:
- Routine clinical care activities
- Standard patient monitoring
- Administrative trial management
- Marketing and commercial activities
Documentation for Clinical Trial Credits
Maintain records showing:
- Technological uncertainty addressed by the trial
- Hypotheses being tested
- Experimental design decisions and alternatives considered
- Time allocation between qualifying and non-qualifying activities
Digital Health & Telemedicine
The digital health sector has exploded in recent years, and much of this development work qualifies for R&D credits.
Qualifying Digital Health Activities
Telemedicine Platforms:
- Video conferencing system development
- Real-time communication optimization
- Multi-device synchronization
- Security and HIPAA compliance architecture
Mobile Health Applications:
- iOS/Android app development for patient engagement
- Wearable device integration
- Real-time health monitoring algorithms
- Push notification and reminder systems
AI and Machine Learning:
- Diagnostic algorithm development
- Natural language processing for clinical notes
- Predictive analytics for patient outcomes
- Image recognition for radiology/pathology
Health Data Analytics:
- Population health dashboards
- Clinical decision support systems
- Claims data analysis platforms
- Real-world evidence generation tools
Software Development Documentation
For software development activities, document:
- Technical challenges being addressed
- Architecture decisions and alternatives evaluated
- Testing methodologies used
- Performance requirements and optimization efforts
See our guide on R&D Tax Credit for Software Companies for detailed software development qualification criteria.
EHR/Health IT Development
Electronic Health Record systems and health IT infrastructure development often contain significant qualifying activities.
Qualifying EHR Activities
Custom Development:
- Proprietary EHR module development
- Custom reporting and analytics tools
- Specialty-specific templates and workflows
- Integration with diagnostic equipment
Interoperability Projects:
- HL7/FHIR interface development
- Health information exchange connectivity
- Third-party system integrations
- Data migration and transformation tools
Patient Portal Development:
- Patient-facing application features
- Appointment scheduling systems
- Secure messaging platforms
- Patient education content management
Clinical Decision Support:
- Alert and reminder system development
- Drug interaction checking algorithms
- Clinical guideline integration
- Order set customization
Hospital System Case Study
Organization: Regional hospital system with 5 facilities Project: Integrated patient care coordination platform
Qualifying Activities:
- Development of cross-facility care coordination workflows
- Real-time patient location tracking system
- Automated discharge planning algorithms
- Integration with external specialist networks
QREs Claimed:
- IT developer wages: $450,000
- Clinical informaticist time: $180,000
- Cloud infrastructure testing: $60,000
- Contractor development services: $120,000
- Total QREs: $810,000
R&D Credit (ASC): Approximately $48,600
Qualifying Expenses for Healthcare R&D
Understanding which expenses qualify is critical for maximizing your R&D tax credit claim.
Qualified Research Expenses (QREs) Categories
| Category | Description | Healthcare Examples |
|---|---|---|
| Wages | Wages paid to employees performing qualified services | Engineers, clinical researchers, software developers, regulatory specialists |
| Supplies | Tangible property used in qualified research | Lab equipment, testing materials, prototype components, clinical trial supplies |
| Contract Research | Payments to contractors for qualified research on behalf of the taxpayer | CRO services, testing laboratories, specialized consultants |
Wage Allocation for Healthcare
Proper wage allocation is essential. The IRS requires allocation between:
- Direct supervision of qualified research
- Direct support of qualified research
- Performance of qualified research
Example Allocation for Clinical Research Coordinator:
- Protocol development: 30% (qualifying)
- Patient recruitment: 20% (partially qualifying if novel)
- Data collection for experimental endpoints: 25% (qualifying)
- Routine patient care: 25% (not qualifying)
- Total qualifying percentage: 75%
For detailed guidance on expense allocation, see our Qualified Research Expenses Breakdown.
Contract Research in Healthcare
Healthcare companies often use extensive contractor services:
- Clinical Research Organizations (CROs)
- Testing laboratories
- Regulatory consultants
- Software development contractors
Important: Only 65% of contract research expenses qualify for the credit, but they can significantly increase your total credit.
Documentation Best Practices
Proper documentation is the difference between a successful credit claim and an IRS challenge. Healthcare companies must maintain contemporaneous records.
Essential Documentation Elements
1. Project Documentation:
- Project charters and objectives
- Technical challenges identified
- Hypotheses and success criteria
- Design alternatives considered
2. Time Tracking:
- Employee-level time allocation by project
- Qualifying vs. non-qualifying activity breakdown
- Supervision and support time documentation
3. Financial Records:
- Payroll records with project allocations
- Invoice and payment documentation for supplies
- Contract agreements with research providers
4. Technical Narratives:
- Description of technological uncertainties
- Explanation of experimental processes
- Results and outcomes documentation
Documentation Templates
Use standardized templates for:
- Project initiation forms (defining research objectives)
- Weekly progress reports (tracking activities and time)
- Technical summaries (documenting uncertainties and experiments)
- Expense tracking logs (allocating costs to projects)
Download our comprehensive R&D Tax Credit Documentation Checklist for healthcare-specific templates.
Common Mistakes to Avoid
Healthcare companies frequently make these mistakes that reduce or eliminate R&D credit claims:
1. Insufficient Documentation
Problem: Failing to maintain contemporaneous records showing how activities meet the four-part test.
Solution: Implement real-time project tracking and documentation systems. Don’t rely on reconstruction after the fact.
2. Over-Allocating Wages
Problem: Claiming 100% of employee wages as qualifying when actual qualifying activities are lower.
Solution: Use reasonable allocation methods based on actual time tracking or representative sampling.
3. Excluding Clinical Trial Activities
Problem: Assuming all clinical trial activities are non-qualifying.
Solution: Carefully analyze Phase I and II trials for qualifying components, particularly protocol development and experimental procedures.
4. Missing Contractor Expenses
Problem: Failing to include payments to CROs, testing labs, and development contractors.
Solution: Review all vendor payments for potential contract research qualification.
5. Claiming Production Activities
Problem: Including routine manufacturing, quality control, or production activities.
Solution: Exclude activities related to commercial production and focus on true research and development.
6. Ignoring Software Development
Problem: Overlooking qualifying software development for internal systems.
Solution: Review all IT and software development projects for potential qualification.
How to Calculate Your Healthcare R&D Credit
The R&D tax credit can be calculated using two methods. Healthcare companies should calculate both and choose the higher amount.
Alternative Simplified Credit (ASC) Method
Formula:
Credit = 50% × (Current Year QREs - Average Prior 3 Years QREs) × 14%
Example:
- 2026 QREs: $2,000,000
- Average 2023-2025 QREs: $1,500,000
- Excess: $500,000
- 50% of excess: $250,000
- Credit: $250,000 × 14% = $35,000
Regular Credit Method
Formula:
Credit = 20% × (Current Year QREs - Base Amount)
Base Amount = Fixed-Base Percentage × Average Prior 4 Years Revenue
The regular method is more complex but can yield higher credits for companies with:
- Rapid R&D growth
- Low historical QREs relative to revenue
- Startup status (no prior years)
Using the Startup Payroll Offset
Qualified small businesses (less than $5M in gross receipts and less than 5 years old) can use R&D credits to offset payroll taxes instead of income taxes.
Payroll Offset Limit: Up to $500,000 per year against FICA employer portion
Eligibility: Many digital health startups qualify for this valuable election.
See our Startup Payroll Tax Offset Guide for detailed eligibility requirements.
Step-by-Step Claim Process
1. Identify Qualifying Activities
Review all research and development activities across:
- Product development (devices, drugs, software)
- Process improvements
- Clinical trials and research
- IT and software development
2. Gather Documentation
Collect:
- Project files and technical documentation
- Payroll and time tracking records
- Vendor invoices and contracts
- Clinical trial protocols and reports
3. Calculate QREs
Allocate expenses to:
- Wages (with time allocation)
- Supplies
- Contract research
4. Calculate Credit
Compute credit under both ASC and Regular methods, choose higher.
5. File with Tax Return
File Form 6765 with your corporate tax return. See our Form 6765 Guide for line-by-line instructions.
6. Maintain Records
Retain all documentation for at least 7 years in case of IRS examination.
Healthcare R&D Credit FAQ
Do clinical trials qualify for R&D tax credits?
Yes, portions of clinical trials can qualify, particularly Phase I and II trials where there is significant uncertainty about safety, efficacy, and optimal protocols. Phase III trials may also qualify if substantial experimental elements remain.
Can hospital systems claim R&D credits?
Yes, hospital systems can claim credits for developing new clinical protocols, custom EHR systems, patient care coordination platforms, and other innovative processes. The key is demonstrating that activities meet the four-part test.
How much can healthcare companies expect in R&D credits?
Credits typically range from 6-10% of qualifying research expenses using the ASC method. For a company with $2M in QREs, expect credits of approximately $100,000-$200,000, depending on historical QREs and calculation method.
Do medical device companies qualify for R&D credits?
Absolutely. Medical device companies are excellent candidates due to extensive prototyping, testing, and FDA approval processes that inherently involve experimentation and technological uncertainty.
What about software development for healthcare applications?
Software development for healthcare applications—including telemedicine platforms, mobile health apps, EHR systems, and AI diagnostic tools—qualifies under the same rules as other software development. See our R&D Credit for Software Companies guide for details.
Can we claim credits for failed research projects?
Yes. The R&D credit is available for qualified research activities regardless of whether they result in successful products or processes. The key is that the activities themselves qualified, not the outcome.
How do I document clinical trial activities for R&D credits?
Maintain contemporaneous records showing:
- Research objectives and hypotheses
- Experimental procedures performed
- Time allocation between qualifying and non-qualifying activities
- Technical challenges and uncertainties addressed
What’s the difference between research and routine testing?
Research involves resolving technological uncertainty through experimentation, while routine testing confirms that products meet established specifications. Only the former qualifies for R&D credits.
Conclusion
Healthcare companies invest heavily in research and development—from medical devices and clinical trials to digital health platforms and EHR systems. The R&D tax credit provides a valuable opportunity to recover a portion of these investments as tax savings.
Key success factors:
- Identify all qualifying activities across your organization
- Maintain contemporaneous documentation showing how activities meet the four-part test
- Allocate expenses carefully to maximize QREs while remaining defensible
- Calculate both credit methods to ensure you’re claiming the maximum benefit
- Work with qualified professionals to navigate complex healthcare-specific issues
For many healthcare companies, R&D credits represent $50,000-$500,000+ in annual tax savings. Don’t leave this money on the table.
Next Steps:
- Review your current R&D activities for qualification potential
- Implement documentation systems if not already in place
- Calculate your potential credit using our R&D Tax Credit Calculator
- Consult with a tax professional experienced in healthcare R&D credits
Related Resources
- R&D Tax Credit Eligibility Basics
- Qualified Research Expenses Breakdown
- R&D Tax Credit Documentation Checklist
- Four-Part Test Guide
- R&D Credit for Biotech Startups
- R&D Credit for Software Companies
Disclaimer: This article provides general information about R&D tax credits for healthcare companies and should not be construed as tax advice. The application of R&D tax credit rules to specific healthcare activities involves complex factual and legal determinations. Consult with a qualified tax professional to evaluate your specific situation. Tax laws change frequently, and the information in this article reflects rules in effect as of 2026 but may not reflect recent changes or your specific circumstances.